Detalles de la búsqueda
1.
Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
PLoS Med
; 18(12): e1003877, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34890407
2.
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
Indian J Med Res
; 152(1 & 2): 48-60, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32952144
3.
Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence survey.
PLoS One
; 18(12): e0294254, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127931
4.
Prevalence and factors associated with tuberculosis infection in India.
J Infect Public Health
; 16(12): 2058-2065, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37948837
5.
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021.
Int J Infect Dis
; 108: 145-155, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34022338
6.
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Lancet Glob Health
; 9(3): e257-e266, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33515512
7.
To start or to complete? - Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India.
Glob Health Action
; 13(1): 1704540, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31937200
8.
HIV Testing among Patients with Presumptive Tuberculosis: How Do We Implement in a Routine Programmatic Setting? Results of a Large Operational Research from India.
PLoS One
; 11(5): e0156487, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27244055
Resultados
1 -
8
de 8
1
Próxima >
>>